To receive the non-invasive sample collection kit please CONTACT US. The necessary request and consent form can be downloaded in our resources section online.
The testing process usually spans up to 2 months, although the average turnaround time is approximately 3 weeks.
Presently, this test does not receive reimbursement from insurance companies.
DNAPLUS strictly adheres to regulatory guidelines aimed at ensuring patient confidentiality and protecting genetic data. All patient information is securely stored in compliance with the General Data Protection Regulation (GDPR).
Our PRS analyses are beneficial for individuals across various demographics, including young, healthy patients keen on understanding their individual risk, those with a family history of a disease interested in genetic influences, and individuals with existing risk factors aiming to assess the impact of genetic factors on their disease risk.
Our tests aid healthcare professionals in accurately reclassifying patients based on their polygenic risk, enabling tailored therapeutic strategies, assisting patients in comprehending their multifaceted risk factors, guiding interventions, and empowering individuals to take proactive steps in reducing their overall disease risk.
PRSs are a promising tool in understanding genetic predispositions for various traits and diseases, driving personalized medicine forward. However, it's crucial to recognize their limitations. PRS aren't diagnostic but indicate potential risk without definitively predicting disease onset. They often don't encompass covariates like monogenic mutations, lifestyle, or family history. Additionally, PRS development based on specific populations can introduce bias when applied elsewhere.
Navigating PRS results is challenging, requiring careful interpretation for both individuals and healthcare professionals.
Despite these challenges, PRS presents an exciting frontier in genetics. They offer a starting point for personalized risk assessment, guiding discussions between patients and healthcare providers. When used in conjunction with other clinical data, PRS contributes to a more comprehensive understanding of genetic predispositions, potentially revolutionizing preventive healthcare strategies.